Memantine Dosing in Patients With Dementia
- 1 February 2009
- journal article
- other
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 17 (2) , 170-173
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Memantine Treatment in Patients with Mild to Moderate Alzheimer's Disease: Results of a Randomised, Double-Blind, Placebo-Controlled 6-Month StudyJournal of Alzheimer’s Disease, 2007
- A 24-week Randomized, Controlled Trial of Memantine in Patients With Moderate-to-severe Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 2007
- Memantine PharmacotherapyClinical Pharmacokinetics, 2007
- Memantine Treatment in Mild to Moderate Alzheimer Disease: A 24-Week Randomized, Controlled TrialThe American Journal of Geriatric Psychiatry, 2006
- Pharmacokinetic study of memantine in healthy and renally impaired subjectsClinical Pharmacology & Therapeutics, 2006
- Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving DonepezilJAMA, 2004
- Memantine in Moderate-to-Severe Alzheimer's DiseaseNew England Journal of Medicine, 2003
- Memantine in severe dementia: results of the9M-best study (benefit and efficacy in severly demented patients during treatment with memantine)International Journal of Geriatric Psychiatry, 1999